KemPharm Inc.

KemPharm Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.51
Market Cap
$45.63 M
Shares Outstanding
28.52 M
Public Float
23.39 M

Profile

Address
1180 Celebration Boulevard
Celebration Florida 34747
United States
Employees -
Website http://www.kempharm.com
Updated 07/08/2019
KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M.

Financials

View All
Created with Highcharts 5.0.14KemPharm Inc.Net Income. Fiscal year is January-December. All values USD Thousands.5 2265 22624 45424 45454 66454 66416 51616 51643 38643 38656 46656 466201320142015201620172018010k20k30k40k50k60k

Travis C. Mickle
Chairman, President & Chief Executive Officer
David S. Tierney
Independent Director